On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
A cost-effectiveness analysis of the DIAFOS trial shows that in-shoe plantar pressure-guided custom footwear saves over €8,000 per ulcer prevented — and adherent patients push the probability of cost-effectiveness to 94%. The economic case for prevention just got stronger.
A new single-center study from the Netherlands quantifies the devastating outcomes of the diabetic foot attack: only 48.5% wound closure, 46% major amputation by 12 months, 26% one-year mortality, and 12-month amputation-free survival of just 39.7%. Time is tissue.
Almelo, Netherlands – June 2025 — In a powerful and thought-provoking keynote at Congres Diabetische Voet 2025, Prof. David G. Armstrong—Founding President of the American Limb Preservation Society (ALPS) and Distinguished Professor of Surgery and Neurological Surgery at USC—delivered the lecture named in honor of the symposium’s founder, Prof. Sjef van Baal. Armstrong’s plenary, titled “Limb Preservation: Looking... Continue Reading →
